News Invivyd Announces Dosing of First Participant in CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of Symptomatic COVID-19 Staff September 11, 2023 Post Navigation Previous Plus Therapeutics Receives $1.9 Million Advance Payment from CPRIT and Plans to Present at the CPRIT Innovations in Cancer Prevention and Research ConferenceNext Major shareholder announcement – BlackRock, Inc. More Stories News Personal Data DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Ascension Health Customers Whose Data May Have Been Compromised Staff December 22, 2024 Cancer Diagnostics Healthcare immunotherapy Mental Health News Art Bio Miami and The Global Passion Projects: Where Scientific Innovation, Creativity and Philanthropy Converge to Transform Lives Staff December 21, 2024 Apps Fitness News Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle Staff December 21, 2024
